The concurrent use of VEGFA-guided NIR fluorescence molecular endoscopy and high-definition white-light endoscopy, following tracer administration, can be used to detect dysplastic and early cancerous lesions in patients with Barrett’s oesophagus. This evidence concerns the gene VEGFA and Barrett esophagus.